News

Science 37 Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution

New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies  LOS ANGELES, January 14, 2020 — Science 37, the industry leader in decentralized clinical trials, recently announced that Jonathan Commons and Darcy Forman have joined the company as vice president of patient engagement and vice president of clinical operations, respectively. The additions help Science 37 extend its market-leading capabilities…

Continue

Science 37® Appoints Steven Geffon as Chief Commercial Officer

Executive role will significantly scale commercial operations and create unparalleled value for clients  LOS ANGELES, December 17, 2019 — Science 37, the industry leader in decentralized clinical trials, announced today that Steven Geffon has joined the company as its chief commercial officer. He will lead commercial operations and strategic partnerships.  Geffon joins Science 37 from Medrio, a leading SaaS data capture platform, where he was responsible for sales and marketing as chief commercial officer. Prior…

Continue

Science 37® Names David Coman Chief Executive Officer

Organization extends its market leadership in the decentralized clinical trial industry LOS ANGELES, November 21, 2019 — Science 37, the industry leader in decentralized clinical trials, announced today that David Coman has joined the company as its chief executive officer. Coman joins Science 37 from ERT, a global data and technology company that helps minimize risk in clinical trials, where he led its data and analytics business after serving as the company’s chief strategy officer.…

Continue

Keck School of Medicine of USC and Science 37® Collaborate on Largest Ever NIH-Funded, Telemedicine-Based Dermatology Study

The two organizations will compare care methods for treating patients with eczema LOS ANGELES, October 1, 2019 — Science 37, the industry leader in virtual clinical trials, and the Keck School of Medicine of the University of Southern California (USC) recently announced a partnership agreement that will support the execution of a $3.4 million study funded by the National Institutes of Health (NIH)—the largest telemedicine-based dermatology study ever funded by the organization. The new collaboration…

Continue

Science 37 Raises $35M in Funding to Continue to Drive Growth – Announces Leadership Transition

Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 – Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is licensing access to its proprietary software platform, NORA® (Network Oriented Research Assistant), which leverages mobile technology and telemedicine capabilities, enabling patients to participate in clinical research studies regardless of their geographical…

Continue

Science 37 and Boehringer Ingelheim Initiate a Collaborative Partnership to Accelerate Patient Centricity in the Development of Novel Therapies

Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 – Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is licensing access to its proprietary software platform, NORA® (Network Oriented Research Assistant), which leverages mobile technology and telemedicine capabilities, enabling patients to participate in clinical research studies regardless of their geographical…

Continue

Science 37 welcomes Judy Smythe as Chief Operating Officer, Bardia Akbari, as the Senior Vice President of Clinical Operations, and Niv Caviar, as Chief Financial Officer

Science 37, a patient-centric clinical trial company announced today that Judy Smythe, MBA, Bardia Akbari, PharmD, and Niv Caviar, MBA have joined the company as their Chief Operating Officer, Senior Vice President of Clinical Operations, and Chief Financial Officer, respectively.

Continue

Science 37 Partners with UCB to Fundamentally Change the Clinical Trial Ecosystem, Focusing on More Patient-Friendly, Technology-Enabled Trials at Home

New collaboration demonstrates full potential of decentralized clinical trials by being more representative of “real life” settings, improving patient access and experience

Continue

Science 37 and VisualDx Partner To Provide A More Patient-First Approach to Decentralized Clinical Research in Dermatology

Healthcare Informatics Company With Proven Products to Enhance Diagnosis Will Partner With End-to-End DCT Platform, Offering Patients and Healthcare Providers a Trusted Medical Resource for Diagnosing Skin Conditions

Continue